- Home
- CAPR vs MMT Comparison
CAPR vs MMT Comparison
Compare CAPR & MMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- MMT
- Stock Information
- Founded
- CAPR 2005
- MMT 1987
- Country
- CAPR United States
- MMT United States
- Employees
- CAPR N/A
- MMT N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- MMT Trusts Except Educational Religious and Charitable
- Sector
- CAPR Health Care
- MMT Finance
- Exchange
- CAPR Nasdaq
- MMT Nasdaq
- Market Cap
- CAPR 332.5M
- MMT 270.5M
- IPO Year
- CAPR N/A
- MMT N/A
- Fundamental
- Price
- CAPR $19.65
- MMT $4.78
- Analyst Decision
- CAPR Strong Buy
- MMT
- Analyst Count
- CAPR 6
- MMT 0
- Target Price
- CAPR $35.50
- MMT N/A
- AVG Volume (30 Days)
- CAPR 1.9M
- MMT 86.5K
- Earning Date
- CAPR 11-13-2024
- MMT 01-01-0001
- Dividend Yield
- CAPR N/A
- MMT 8.58%
- EPS Growth
- CAPR N/A
- MMT N/A
- EPS
- CAPR N/A
- MMT 0.30
- Revenue
- CAPR $27,152,218.00
- MMT N/A
- Revenue This Year
- CAPR N/A
- MMT N/A
- Revenue Next Year
- CAPR $135.53
- MMT N/A
- P/E Ratio
- CAPR N/A
- MMT $15.33
- Revenue Growth
- CAPR 187.15
- MMT N/A
- 52 Week Low
- CAPR $2.68
- MMT $4.04
- 52 Week High
- CAPR $23.40
- MMT $4.70
- Technical
- Relative Strength Index (RSI)
- CAPR 53.80
- MMT 43.17
- Support Level
- CAPR $17.50
- MMT $4.72
- Resistance Level
- CAPR $20.37
- MMT $4.83
- Average True Range (ATR)
- CAPR 1.57
- MMT 0.04
- MACD
- CAPR -0.73
- MMT -0.00
- Stochastic Oscillator
- CAPR 24.91
- MMT 22.73
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
About MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.